VENTYX BIOSCIENCES INC. - COMMON STOCK

Ventyx Biosciences Announces Completion of Enrollment of the Phase 2 Trial of VTX002 in Ulcerative Colitis and the Phase 2 Trial of VTX958 in Plaque Psoriasis

07 июн 2023 04:00:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

31 май 2023 05:00:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Progress

11 май 2023 13:01:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Report First Quarter 2023 Financial Results on May 11, 2023

04 май 2023 13:05:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in the H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference

24 мар 2023 05:00:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Corporate Progress

23 мар 2023 13:01:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on March 23, 2023

15 мар 2023 13:05:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Provides Update on Silicon Valley Bank Financial Exposure

11 мар 2023 10:21:31 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

28 фев 2023 05:00:03 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Announces Pipeline Updates and Highlights Strategic Priorities at Investor R&D Day

26 янв 2023 05:00:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Appoints Allison J. Hulme, Ph.D. and Onaiza Cadoret-Manier to its Board of Directors

12 янв 2023 05:00:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Host R&D Event on January 26, 2023

05 янв 2023 05:00:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Announces Dosing of the First Patient in the Phase 2 SERENITY Trial of VTX958 for the Treatment of Moderate to Severe Plaque Psoriasis

01 дек 2022 13:05:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

22 ноя 2022 05:00:02 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress

03 ноя 2022 13:01:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Report Third Quarter 2022 Financial Results on November 3, 2022

27 окт 2022 13:05:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Three Upcoming Investor Conferences

27 окт 2022 06:00:01 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Announces $176.6 Million Private Placement of Common Stock

19 сен 2022 05:00:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences to Participate in Two Upcoming Investor Conferences

29 авг 2022 13:05:00 Источник Nasdaq GlobeNewswire

Ventyx Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress

15 авг 2022 13:05:01 Источник Nasdaq GlobeNewswire